[1] Huntington’s Disease Collaborative Research Group (1993) A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington’s Disease Chromosomes. Cell, 72, 971-983.
http://dx.doi.org/10.1016/0092-8674(93)90585-E
[2] Rubinsztein, D.C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J.J., Chotai, K., Connarty, M., Crauford, D., Curtis, A., Curtis, D., Davidson, M.J., Differ, A.M., Dode, C., Dodge, A., Frontali, M., Ranen, N.G., Stine, O.C., Sherr, M., Abbott, M.H., Franz, M.L., Graham, C.A., Harper, P.S., Hedreen, J.C. and Hayden, M.R. (1996) Phenotypic Characterization of Individuals with 30-40 CAG Repeats in the Huntington Disease (HD) Gene Reveals HD Cases with 36 Repeats and Apparently Normal Elderly Individuals with 36-39 Repeats. American Journal of Human Genetics, 59, 16-22.
[3] Bates, G., Harper, P.S. and Jones, L. (2002) Huntington’s Disease. 3rd Edition, Oxford University Press, Oxford.
[4] Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S. and Hayden, M.R. (2004) A New Model for Prediction of the Age of Onset and Penetrance for Huntington’s Disease Based on CAG Length. Clinical Genetics, 65, 267-277.
http://10.1111/j.1399-0004.2004.00241.x
[5] Roos, R.A., Vegtervan der Vlis, M., Hermans, J., Elshove, H.M., Moll, A.C., van de Kamp, J.J. and Bruyn, G.W. (1991) Age at Onset in Huntington’s Disease: Effect of Line of Inheritance and Patient’s Sex. Journal of Medical Genetics, 28, 515-519.
http://jmg.bmj.com
http://dx.doi.org/10.1136/jmg.28.8.515
[6] Gusella, J.F., Wexler, N.S., Conneally, P.M., Naylor, S.L., Anderson, M.A., Tanzi, R.E., Watkins, P.C., Ottina, K., Wallace, M.R., Sakaguchi, A.Y., Young, A.B., Shoulson, I., Bonilla, E. and Martin, J.B. (1983) A Polymorphic DNA Marker Genetically Linked to Huntington’s Disease. Nature, 306, 234-238.
http://dx.doi.org/10.1038/306234a0
[7] Brandt, J., Shpritz, B., Codori, A.-M., Margolis, R. and Rosenblatt, A. (2002) Neuropsychological Manifestations of the Genetic Mutation for Huntington’s Disease in Presymptomatic Individuals. Journal of the International Neuropsychological Society, 8, 918-924.
http://dx.doi.org/10.1017/S1355617702870060
[8] Larsson, M.U., Almkvist, O., Luszcz, M.A. and Robins Wahlin, T.-B. (2008) Phonemic Fluency Deficits in Asymptomatic Gene Carriers for Huntington’s Disease. Neuropsychology, 22, 596-605.
http://dx.doi.org/10.1037/0894-4105.22.5.596
[9] Paulsen, J.S., Langbehn, D.R., Stout, J.C., Aylward, E., Ross, C.A., Nance, M., Guttman, M., Johnson, S., MacDonald, M., Beglinger, L.J., Duff, K., Kayson, E., Biglan, K., Shoulson, I., Oakes, D. and Hayden, M. (2008) Detection of Huntington’s Disease Decades before Diagnosis: The Predict-HD Study. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 874-880.
http://dx.doi.org/10.1136/jnnp.2007.128728
[10] Robins Wahlin, T.-B., Larsson, M. and Luszcz, M. (2010) WAIS-R Features of Preclinical Huntington’s Disease: Implications for Early Detection. Dementia and Geriatric Cognitive Disorders, 29, 342-350.
http://dx.doi.org/10.1159/000288775
[11] Robins Wahlin, T.-B., Lundin, A. and Dear, K. (2007) Early Cognitive Deficits in Swedish Gene Carriers of Huntington’s Disease. Neuropsychology, 21, 31-44.
http://dx.doi.org/10.1037/0894-4105.21.1.31
[12] Stout, J.C., Paulsen, J.S., Queller, S., Solomon, A.C., Whitlock, K.B., Campbell, J.C., Carlozzi, N., Duff, K., Beglinger, L.J., Langbehn, D.R., Johnson, S.A., Biglan, K.M. and Aylward, E.H. (2011) Neurocognitive Signs in Prodromal Huntington Disease. Neuropsychology, 25, 1-14.
http://dx.doi.org/10.1037/a0020937
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017660/pdf/nihms224607.pdf
[13] Harrington, D.L., Smith, M.M., Zhang, Y., Carlozzi, N.E. and Paulsen, J.S. (2012) Cognitive Domains That Predict Time to Diagnosis in Prodromal Huntington Disease. Journal of Neurology, Neurosurgery and Psychiatry, 83, 612-619.
http://jnnp.bmj.com/content/83/6/612.full.pdf
http://dx.doi.org/10.1136/jnnp-2011-301732
[14] Solomon, A.C., Stout, J.C., Johnson, S.A., Langbehn, D.R., Aylward, E.H., Brandt, J., Ross, C.A., Beglinger, L., Hayden, M.R., Kieburtz, K., Kayson, E., Julian-Baros, E., Duff, K., Guttman, M., Nance, M., Oakes, D., Shoulson, I., Penziner, E. and Paulsen, J.S. (2007) Verbal Episodic Memory Declines Prior to Diagnosis in Huntington’s Disease. Neuropsychologia, 45, 1767-1776.
http://dx.doi.org/10.1016/j.neuropsychologia.2006.12.015
[15] Butters, N., Sax, D., Montgomery, K. and Tarlow, S. (1978) Comparison of the Neuropsychological Deficits Associated with Early and Advanced Huntington’s Disease. Archives of Neurology, 35, 585-589.
http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=150836&site=ehost-live
http://dx.doi.org/10.1001/archneur.1978.00500330033006
[16] Montoya, A., Pelletier, M., Menear, M., Duplessis, E., Richer, F. and Lepage, M. (2006) Episodic Memory Impairment in Huntington’s Disease: A Meta-Analysis. Neuropsychologia, 44, 1984-1994.
http://dx.doi.org/10.1016/j.neuropsychologia.2006.01.015
[17] Caine, E.D., Hunt, R.D., Weingartner, H. and Ebert, M.H. (1978) Huntington’s Dementia. Clinical and Neuropsychological Features. Archives of General Psychiatry, 35, 377-384.
http://dx.doi.org/10.1001/archpsyc.1978.01770270127013
[18] Beglinger, L.J., O’Rourke, J.J., Wang, C., Langbehn, D.R., Duff, K. and Paulsen, J.S. (2010) Earliest Functional Declines in Huntington Disease. Psychiatry Research, 178, 414-418.
http://dx.doi.org/10.1016/j.psychres.2010.04.030
http://ac.els-cdn.com/S0165178110001897/1-s2.0-S0165178110001897-main.pdf?_tid=15748d52-cf18-11e4-89b8-00000aab0f02&acdnat=1426866487_8f95e4d5d9b7c9e335bdc65bc9ebbcfe
[19] Dorsey, E.R., Beck, C.A., Darwin, K., Nichols, P., Brocht, A.F., Biglan, K.M. and Shoulson, I. (2013) Natural History of Huntington Disease. JAMA Neurology, 70, 1520-1530.
http://archneur.jamanetwork.com/data/Journals/NEUR/929441/noi130064.pdf
[20] Williams, J.K., Hamilton, R., Nehl, C., McGonigal-Kenney, M., Schutte, D.L., Sparbel, K., Birrer, E., Tripp-Reimer, T., Friedrich, R., Penziner, E., Jarmon, L. and Paulsen, J. (2007) No One Else Sees the Difference: “Family Members” Perceptions of Changes in Persons with Preclinical Huntington Disease. American Journal of Medical Genetics B Neuropsychiatric Genetics, 144, 636-641.
http://dx.doi.org/10.1002/ajmg.b.30479
[21] Zakzanis, K.K. (1998) The Subcortical Dementia of Huntington’s Disease. Journal of Clinical and Experimental Neuropsychology, 20, 565-578.
http://dx.doi.org/10.1076/jcen.20.4.565.1468
[22] Pillon, B., Deweer, B., Agid, Y. and Dubois, B. (1993) Explicit Memory in Alzheimer’s, Huntington’s, and Parkinson’s Diseases. Archives of Neurology, 50, 374-379.
http://dx.doi.org/10.1001/archneur.1993.00540040036010
[23] Fuld, P.A. (1980) Guaranteed Stimulus-Processing in the Evaluation of Memory and Learning. Cortex, 16, 255-271.
http://dx.doi.org/10.1016/S0010-9452(80)80061-X
[24] Hill, R.D., Neely, A.S. and Backman, L. (1997) Predictors of Change on the Fuld Object Memory Evaluation in a Two-Year Longitudinal Study of Optimally Healthy Very Old Adults. Aging and Mental Health, 1, 140-148.
http://dx.doi.org/10.1080/13607869757236
[25] Wall, J.R., Deshpande, S.A., MacNei, S.E. and Lichtenberg, P.A. (1998) The Fuld Object Memory Evaluation, a Useful Tool in the Assessment of Urban Geriatric Patients. Clinical Gerontologist, 19, 39-49.
http://dx.doi.org/10.1300/J018v19n01_04
[26] Mastroberardino, S., Santangelo, V., Botta, F., Marucci, F. and Olivetti Belardinelli, M. (2008) Guaranteed Stimulus-Processing in the Evaluation of Memory and Learning. Cognitive Processing, 9, 69-76.
http://dx.doi.org/10.1007/s10339-007-0195-6
[27] Buschke, H. (1973) Selective Reminding for Analysis of Memory and Learning. Journal of Verbal Learning and Verbal Behavior, 12, 543-550.
http://dx.doi.org/10.1016/S0022-5371(73)80034-9
[28] Claeson, L.E., Esbjörnsson, E., Carlé, B.M. and Wahlbin, M. (1971) Claeson-Dahls inlärningstest för kliniskt bruk (Claeson-Dahl’s Learning Test). Psykologiförlaget AB, Stockholm.
[29] Folstein, S.E., Jensen, B., Leigh, R.J. and Folstein, M.F. (1983) The Measurement of Abnormal Movement: Methods Developed for Huntington’s Disease. Neurobehavioral Toxicology and Teratology, 5, 605-609.
[30] Robins Wahlin, T.-B., Bäckman, L., Lundin, A., Haegermark, A., Winblad, B. and Anvret, M. (2000) High Suicidal Ideation in Persons Testing for Huntington’s Disease. Acta Neurologica Scandinavica, 102, 150-161.
http://dx.doi.org/10.1034/j.1600-0404.2000.102003150.x
[31] Langbehn, D.R., Hayden, M.R. and Paulsen, J.S. (2010) CAG-Repeat Length and the Age of Onset in Huntington Disease (HD): A Review and Validation Study of Statistical Approaches. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 9999B, 397-408.
http://dx.doi.org/10.1002/ajmg.b.30992
[32] Lezak, M.D., Howieson, D.B. and Loring, D.W. (2004) Neuropsychological Assessment. 4th Edition, Oxford University Press, New York.
[33] Beck, A.T., Ward, C.H., Mendelson, M., Mock, J. and Erbaugh, J. (1961) An Inventory for Measuring Depression. Archives of General Psychiatry, 4, 561-571.
http://dx.doi.org/10.1001/archpsyc.1961.01710120031004
[34] Paulsen, J.S., Salmon, D.P., Monsch, A.U., Butters, N., Swenson, M.R. and Bondi, M.W. (1995) Discrimination of Cortical from Subcortical Dementias on the Basis of Memory and Problem-Solving Tests. Journal of Clinical Psychology, 51, 48-58.
http://dx.doi.org/10.1002/1097-4679(199501)51:1<48::AID-JCLP2270510109>3.0.CO;2-E
[35] Butters, N., Wolfe, J., Martone, M., Granholm, E. and Cermak, L.S. (1985) Memory Disorders Associated with Huntington’s Disease: Verbal Recall, Verbal Recognition and Procedural Memory. Neuropsychologia, 23, 729-743.
http://dx.doi.org/10.1016/0028-3932(85)90080-6
[36] Lundervold, A.J. (1994) Characteristic Pattern of Verbal Memory Function in Patients with Huntington’s Disease. Scandinavian Journal of Psychology, 35, 38-47.
http://dx.doi.org/10.1111/j.1467-9450.1994.tb00931.x
[37] Perry, R.J. and Hodges, J.R. (1996) Spectrum of Memory Dysfunction in Degenerative Disease. Current Opinion in Neurology, 9, 281-285.
http://dx.doi.org/10.1097/00019052-199608000-00007
[38] Bäckman, L. and Nilsson, L. (1985) Prerequisites for Lack of Age Differences in Memory Performance. Experimental Aging Research, 11, 67-73.
http://dx.doi.org/10.1080/03610738508259282
[39] Baddeley, A. (2003) Working Memory: Looking Back and Looking Forward. Nature Reviews Neuroscience, 4, 829-839.
http://dx.doi.org/10.1038/nrn1201
[40] Weible, J., Nuest, B., Welty, J., Pate, W. and Turner, M. (2002) Demonstrating the Effects of Presentation Rate on Aging Memory Using the California Verbal Learning Test (CVLT). Aging, Neuropsychology, and Cognition (Neuropsychology, Development and Cognition), 9, 38-47.
http://dx.doi.org/10.1076/anec.9.1.38.834
[41] Aylward, E.H., Sparks, B.F., Field, K.M., Yallapragada, V., Shpritz, B.D., Rosenblatt, A., Brandt, J., Gourley, L.M., Liang, K., Zhou, H., Margolis, R.L. and Ross, C.A. (2004) Onset and Rate of Striatal Atrophy in Preclinical Huntington Disease. Neurology, 63, 66-72.
http://dx.doi.org/10.1212/01.WNL.0000132965.14653.D1
[42] Bonner-Jackson, A., Long, J.D., Westervelt, H., Tremont, G., Aylward, E. and Paulsen, J.S. (2013) Cognitive Reserve and Brain Reserve in Prodromal Huntington’s Disease. Journal of the International Neuropsychological Society, 19, 739-750.
http://dx.doi.org/10.1017/S1355617713000507
http://journals.cambridge.org/download.php?file=%2FINS%2FINS19_07%2FS1355617713000507a.pdf&code=
0a2ccdf33aa4a88250aadfcbedad50cd
[43] Aylward, E.H., Harrington, D.L., Mills, J.A., Nopoulos, P.C., Ross, C.A., Long, J.D., Liu, D., Westervelt, H.K. and Paulsen, J.S. (2013) Regional Atrophy Associated with Cognitive and Motor Function in Prodromal Huntington Disease. Journal of Huntingtons Disease, 2, 477-489.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412155/pdf/nihms640985.pdf
[44] Montoya, A., Price, B.H., Menear, M. and Lepage, M. (2006) Brain Imaging and Cognitive Dysfunctions in Huntington’s Disease. Journal of Psychiatry & Neuroscience, 31, 21-29.
Copyright 2015, 8872147 Canada Inc.
[45] Paulsen, J.S. (2009) Functional Imaging in Huntington’s Disease. Experimental Neurology, 216, 272-277.
http://www.sciencedirect.com/science/article/B6WFG-4V94X1C-1/2/46f187d39554216f33bec0cc0f9d2d04
http://dx.doi.org/10.1016/j.expneurol.2008.12.015
[46] Rosas, H.D., Hevelone, N.D., Zaleta, A.K., Greve, D.N., Salat, D.H. and Fischl, B. (2005) Regional Cortical Thinning in Preclinical Huntington Disease and Its Relationship to Cognition. Neurology, 65, 745-747.
http://dx.doi.org/10.1212/01.wnl.0000174432.87383.87
[47] Wolf, R.C., Vasic, N., Schonfeldt-Lecuona, C., Landwehrmeyer, G.B. and Ecker, D. (2007) Dorsolateral Prefrontal Cortex Dysfunction in Presymptomatic Huntington’s Disease: Evidence from Event-Related fMRI. Brain, 130, 2845.
http://dx.doi.org/10.1093/brain/awm210
[48] Wolf, R.C., Sambataro, F., Vasic, N., Schönfeldt-Lecuona, C., Ecker, D. and Landwehrmeyer, B. (2008) Aberrant Connectivity of Lateral Prefrontal Networks in Presymptomatic Huntington’s Disease. Experimental Neurology, 213, 137-144.
http://dx.doi.org/10.1016/j.expneurol.2008.05.017
[49] Wolf, R.C., Thomann, P.A., Thomann, A.K., Vasic, N., Wolf, N.D., Landwehrmeyer, G.B. and Orth, M. (2013) Brain Structure in Preclinical Huntington’s Disease: A Multi-Method Approach. Neuro-Degenerative Diseases, 12, 13-22.
http://www.karger.com/Article/Pdf/338635
http://dx.doi.org/10.1159/000338635
[50] Wolf, R.C., Sambataro, F., Vasic, N., Wolf, N.D., Thomann, P.A., Landwehrmeyer, G.B. and Orth, M. (2014) Longitudinal Task-Negative Network Analyses in Preclinical Huntington’s Disease. European Archives of Psychiatry and Clinical Neuroscience, 264, 493-505.
http://www.ncbi.nlm.nih.gov/pubmed/24071913
http://dx.doi.org/10.1007/s00406-013-0447-7
[51] Dogan, I., Eickhoff, S.B., Schulz, J.B., Shah, N.J., Laird, A.R., Fox, P.T. and Reetz, K. (2013) Consistent Neurodegeneration and Its Association with Clinical Progression in Huntington’s Disease: A Coordinate-Based Meta-Analysis. Neuro-Degenerative Diseases, 12, 23-35.
http://www.karger.com/Article/Pdf/339528
http://dx.doi.org/10.1159/000339528
[52] Paulsen, J.S., Long, J.D., Johnson, H.J., Aylward, E.H., Ross, C.A., Williams, J.K., Nance, M.A., Erwin, C.J., Westervelt, H.J., Harrington, D.L., Bockholt, H.J., Zhang, Y., McCusker, E.A., Chiu, E.M. and Panegyres, P.K. (2014) Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study. Frontiers in Aging Neuroscience, 6, 78.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000999/pdf/fnagi-06-00078.pdf
http://dx.doi.org/10.3389/fnagi.2014.00078
[53] Robins Wahlin, T.-B. and Byrne, G.J. (2012) Cognition in Huntington’s Disease. In: Tunali, N.E., Ed., Huntington’s Disease—Core Concepts and Current Advances, InTech, Rijeka, 175-200.
http://www.intechopen.com/articles/show/title/cognition-in-huntington-s-disease
[54] Beatty, W.W., Krull, K.R., Wilbanks, S.L., Blanco, C.R., Hames, K.A. and Paul, R.H. (1996) Further Validation of Constructs from the Selective Reminding Test. Journal of Clinical and Experimental Neuropsychology, 18, 52-55.
http://dx.doi.org/10.1080/01688639608408261
[55] Biringer, E., Rongve, A. and Lund, A. (2009) A Review of Modern Antidepressants Effects on Neurocognitive Function. Current Psychiatry Reviews, 5, 164-174.
http://dx.doi.org/10.2174/157340009788971137
[56] Kremer, B., Almqvist, E., Theilmann, J., Spence, N., Telenius, H., Goldberg, Y.P. and Hayden, M.R. (1995) Sex-Dependent Mechanisms for Expansions and Contractions of the CAG Repeat on Affected Huntington Disease Chromosomes. American Journal of Human Genetics, 57, 343-350.
http://www.ncbi.nlm.nih.gov